Novo Nordisk AS (NVO)
105.40
-1.51
(-1.41%)
USD |
NYSE |
Nov 14, 16:00
105.06
-0.34
(-0.32%)
After-Hours: 20:00
Novo Nordisk Gross Profit (Annual): 28.53B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 28.53B |
December 31, 2022 | 21.05B |
December 31, 2021 | 18.64B |
December 31, 2020 | 16.24B |
December 31, 2019 | 15.28B |
December 31, 2018 | 14.92B |
December 31, 2017 | 14.32B |
December 31, 2016 | 14.06B |
December 31, 2015 | 13.65B |
December 31, 2014 | 13.24B |
December 31, 2013 | 12.36B |
December 31, 2012 | 11.15B |
December 31, 2011 | 10.04B |
December 31, 2010 | 8.740B |
December 31, 2009 | 7.606B |
December 31, 2008 | 7.000B |
December 31, 2007 | 5.900B |
December 31, 2006 | 4.912B |
December 31, 2005 | 4.100B |
December 31, 2004 | 3.534B |
Date | Value |
---|---|
December 31, 2003 | 2.915B |
December 31, 2002 | 2.358B |
December 31, 2001 | 2.134B |
December 31, 2000 | 2.037B |
December 31, 1999 | 1.837B |
December 31, 1998 | 1.559B |
December 31, 1997 | 1.860B |
December 31, 1996 | 1.852B |
December 31, 1995 | 1.765B |
December 31, 1994 | 1.526B |
December 31, 1993 | 1.041B |
December 31, 1992 | 1.352B |
December 31, 1991 | 789.15M |
December 31, 1990 | 681.45M |
December 31, 1989 | 528.06M |
December 31, 1988 | 433.72M |
December 31, 1987 | 356.81M |
December 31, 1986 | 110.76M |
December 31, 1985 | 198.34M |
December 31, 1984 | 169.47M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
15.28B
Minimum
2019
28.53B
Maximum
2023
19.95B
Average
18.64B
Median
2021
Gross Profit (Annual) Benchmarks
Ascendis Pharma AS | 240.69M |
Amgen Inc | 19.74B |
AstraZeneca PLC | 37.54B |
Grifols SA | 2.701B |
Viking Therapeutics Inc | -- |